A clotbusting drug commonly used to treat ischemic stroke interacts negatively with a promising anti-inflammatory treatment (anakinra), underscoring the need to test new stroke therapies alongside ...

Stroke treatment hardware developer Imperative Care has posted a $100 million funding round to support its commercial growth and research into its upcoming robotic platform. | The former Fierce ...

NEW YORK, Feb. 18, 2025 /PRNewswire/ -- Remedy Pharmaceuticals, a leader in stroke drug development today announced efficacy data from the Phase 2 GAMES-RP and Phase 3 CHARM studies of CIRARA ...

Endovascular robot developer XCath said it has successfully completed its first remotely operated stroke procedure, linking a neurosurgeon with a patient more than a hundred miles away.

Route 92 advances stroke care with the SUMMIT RISE study and innovation amid growing competition in the market.

In a landmark achievement that could redefine the future of healthcare, Remedy Robotics has successfully secured $35 million in funding. This monumental step is aimed at advancing their innovative ...

Stroke remains one of Malaysia’s most pressing health challenges, consistently ranking among the country’s top causes of ...

Across hospitals and health systems, stroke care sits at the intersection of several pressures leaders know well: rising acuity, uneven access to specialty care, workforce constraints and growing ...

In a significant boost to Bangladesh’s healthcare sector, Bangladesh Medical University (BMU) has been accredited as an international training ...